SYS-CON MEDIA Authors: Kevin Benedict, Gilad Parann-Nissany, Peter Silva, Unitiv Blog, RealWire News Distribution

News Feed Item

Johnson & Johnson Professional Export is Honored to be Named Winner of the Queen's Award for Enterprise - the UK's Highest Accolade for Business Success

LONDON, April 21, 2014 /PRNewswire/ --


Today, UK-based Johnson & Johnson Professional Export, a division of Johnson & Johnson Medical Ltd, is proud to celebrate the honor of winning the Queen's Award for Enterprise.  The award for 'International Trade' was given in recognition of their successful domestic and international strategies which have widened access to their extensive range of medical devices and diagnostic products in emerging markets including Iran, Malta/Gibraltar and Sub-Saharan Africa.

"Our vision is to significantly increase the number of healthcare professionals and ultimately patients who benefit from our advanced medical devices and diagnostic products. By achieving consistent growth we have been able to increase  investment  in this region, offering the best possible training for healthcare professionals while building valuable partnerships with local organizations, businesses and customers in both the UK and Emerging Markets," said Johnson & Johnson Professional Export Managing Director, Ian Walker.

Johnson & Johnson Professional Export prides itself on being a dynamic, customer-driven organization that operates through 45 distributors in 43 countries. Receiving a prestigious Queen's Award not only acknowledges the company's continued commitment to improving healthcare through Corporate Social Responsibility  initiatives in Africa, but its significant investment in training and education.

For example, Johnson & Johnson offers unique local education programs for surgeons in Sub-Saharan Africa, establishing two regional training centres in Ghana and Kenya in partnership with Korle Bu Hospital in Accra and Nairobi University Medical School.  Through these facilities, Johnson & Johnson has been able to train in excess of 1,200 healthcare professionals across a range of surgical procedures, enabling expanded access to healthcare for patients in parts of the region that have historically been more challenging to reach.

EMEA Company Group Chairman Sabine Dandiguian said, "Inspired by Our Credo, Johnson & Johnson is working to ensure emerging markets such as Sub-Saharan Africa gain access to the best possible healthcare. We are proud that Johnson & Johnson Professional Export has been awarded such a prestigious accolade to recognize their business and community impact in this region."

As a winner of the Queen's Award for Enterprise, Johnson & Johnson Professional Export will be invited to attend a special reception at Buckingham Palace later this year.

Johnson & Johnson Professional Export, a division of Johnson & Johnson Medical Ltd is based at Kirkton Campus, Livingston, Scotland.

Notes to Editors 

About Johnson & Johnson  

Caring for the world one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,000 employees at more than 275 Johnson & Johnson operating companies work with partners in healthcare to touch the lives of over a billion people throughout the world every day.  For more information please visit http://www.jnj.com.

About the Queen's Award 

Approximately 160 Queen's Awards have been announced this year for outstanding business achievement in the fields of International Trade, Innovation and Sustainable Development.

The awards are made annually by HM The Queen, and are only given for the highest levels of excellence demonstrated in each category. To find out more visit http://www.queendsawards.org.uk.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.